Latest revenue
$965.1M
as of 2026-03-31
Latest net income
$14.4M
as of 2026-03-31
Net margin
1.5%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $2.11B
- Enterprise value
- $2.11B
- P/E (trailing)
- 93.8×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $39.93
- 52-wk low
- $18.08
- Beta
- —
- Shares out
- 55.7M
5-year trend
What this company does
Item 1. Business Overview Astrana is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner. We, together with our affiliated physician groups and consolidated subsidiaries and VIEs, provide coordinated outcome-based care, serving patients covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations (“HMOs”),…
AI summary unavailable — showing raw filing excerpt
Generated from ASTH's filing dated 2026-03-12
Key risks
Item 1A. Risk Factors Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information in this Annual Report on Form 10-K, including the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7, and our consolidated financial statements and related notes, before making a decision to invest in our common stock. Although the risks are organized by headings and each risk is discussed separately, many are interrelated. Disclosures of risks should not be interpreted to imply that the risks have not already…
AI summary unavailable — showing raw filing excerpt
Generated from ASTH's filing dated 2026-03-12
Profitability
Operating margin
2.5%
43.8%Net margin
0.7%
66.7%Return on equity
2.9%
52.3%Return on assets
1.0%
68.2%Leverage
Debt / equity
1.85×
105.0%Long-term debt / equity
1.27×
113.1%Debt / assets
64.9%
36.9%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $965.1M | +55.6% | $14.4M | +115.7% | 1.5% |
Q4 2025 2025-12-31 | $950.5M | +42.9% | $6.0M | +186.3% | 0.6% |
Q3 2025 2025-09-30 | $956.0M | +99.7% | $373.0K | -97.7% | 0.0% |
Q2 2025 2025-06-30 | $654.8M | +34.7% | $9.4M | -50.8% | 1.4% |
Q1 2025 2025-03-31 | $620.4M | +53.4% | $6.7M | -54.9% | 1.1% |
Q4 2024 2024-12-31 | $665.2M | — | $-7.0M | — | -1.0% |
Q3 2024 2024-09-30 | $478.7M | +37.5% | $16.1M | -27.0% | 3.4% |
Q2 2024 2024-06-30 | $486.3M | +39.6% | $19.2M | +45.6% | 3.9% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Management Consulting Services · SIC 8742
Your notes
Keep private notes on ASTH — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$0
Net activity
+$0
Distinct insiders
0
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value |
|---|
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ASTH
Institutional value
$419.2M
Total shares held
17.3M
Distinct holders
104
-71 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.2M | $151.1M | +6.0K (+0.1%) | Added |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.3M | $55.8M | — | New |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | $41.9M | — | New |
| 4 | DIMENSIONAL FUND ADVISORS LP | 1.4M | $33.5M | +152.3K (+12.5%) | Added |
| 5 | SteelPeak Wealth, LLC | 559.9K | $13.7M | -20.0K (-3.4%) | Trimmed |
| 6 | DIAMOND HILL CAPITAL MANAGEMENT INC | 544.0K | $13.3M | +111.3K (+25.7%) | Added |
| 7 | ROYCE & ASSOCIATES LP | 397.0K | $9.7M | +48.6K (+14.0%) | Added |
| 8 | Invesco Ltd. | 351.1K | $8.6M | -4.1K (-1.2%) | Trimmed |
| 9 | LPL Financial LLC | 309.1K | $7.6M | +0 (+0.0%) | No change |
| 10 | UBS Group AG | 301.9K | $7.4M | +125.8K (+71.5%) | Added |
| 11 | VANGUARD FIDUCIARY TRUST CO | 293.0K | $7.2M | — | New |
| 12 | PRINCIPAL FINANCIAL GROUP INC | 265.9K | $6.5M | +36.1K (+15.7%) | Added |
| 13 | Bank of New York Mellon Corp | 221.8K | $5.4M | -7.8K (-3.4%) | Trimmed |
| 14 | Public Sector Pension Investment Board | 154.3K | $3.8M | +5.0K (+3.3%) | Added |
| 15 | 1492 Capital Management LLC | 153.7K | $3.8M | -14.1K (-8.4%) | Trimmed |
| 16 | Insight Wealth Strategies, LLC | 143.3K | $3.5M | +1.6K (+1.2%) | Added |
| 17 | ENVESTNET ASSET MANAGEMENT INC | 138.4K | $3.4M | +12.1K (+9.6%) | Added |
| 18 | SEI INVESTMENTS CO | 134.9K | $3.3M | +65.5K (+94.4%) | Added |
| 19 | WELLS FARGO & COMPANY/MN | 103.0K | $2.5M | -13.3K (-11.4%) | Trimmed |
| 20 | RHUMBLINE ADVISERS | 100.6K | $2.5M | +4.7K (+4.9%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ASTH's latest filing finishes processing.